314 related articles for article (PubMed ID: 26725515)
1. Mechanism of FGF receptor dimerization and activation.
Sarabipour S; Hristova K
Nat Commun; 2016 Jan; 7():10262. PubMed ID: 26725515
[TBL] [Abstract][Full Text] [Related]
2. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
Sarabipour S; Hristova K
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
[TBL] [Abstract][Full Text] [Related]
3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
Li E; You M; Hristova K
Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
[TBL] [Abstract][Full Text] [Related]
4. The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C-terminal juxtamembrane residues.
Peng WC; Lin X; Torres J
Protein Sci; 2009 Feb; 18(2):450-9. PubMed ID: 19165726
[TBL] [Abstract][Full Text] [Related]
5. FGFR3 unliganded dimer stabilization by the juxtamembrane domain.
Sarabipour S; Hristova K
J Mol Biol; 2015 Apr; 427(8):1705-14. PubMed ID: 25688803
[TBL] [Abstract][Full Text] [Related]
6. Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.
Chellaiah A; Yuan W; Chellaiah M; Ornitz DM
J Biol Chem; 1999 Dec; 274(49):34785-94. PubMed ID: 10574949
[TBL] [Abstract][Full Text] [Related]
7. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
8. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
Safran M; Eisenstein M; Aviezer D; Yayon A
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
[TBL] [Abstract][Full Text] [Related]
10. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
11. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
Lopez ME; Korc M
J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for fibroblast growth factor receptor activation.
Mohammadi M; Olsen SK; Ibrahimi OA
Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.
Plotnikov AN; Hubbard SR; Schlessinger J; Mohammadi M
Cell; 2000 May; 101(4):413-24. PubMed ID: 10830168
[TBL] [Abstract][Full Text] [Related]
14. Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1.
Beenken A; Eliseenkova AV; Ibrahimi OA; Olsen SK; Mohammadi M
J Biol Chem; 2012 Jan; 287(5):3067-78. PubMed ID: 22057274
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL; Kan M
Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
[TBL] [Abstract][Full Text] [Related]
16. The physical basis of FGFR3 response to fgf1 and fgf2.
Chen F; Hristova K
Biochemistry; 2011 Oct; 50(40):8576-82. PubMed ID: 21894939
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for FGF receptor dimerization and activation.
Plotnikov AN; Schlessinger J; Hubbard SR; Mohammadi M
Cell; 1999 Sep; 98(5):641-50. PubMed ID: 10490103
[TBL] [Abstract][Full Text] [Related]
18. Structural interactions of fibroblast growth factor receptor with its ligands.
Stauber DJ; DiGabriele AD; Hendrickson WA
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):49-54. PubMed ID: 10618369
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs.
Terada M; Shimizu A; Sato N; Miyakaze SI; Katayama H; Kurokawa-Seo M
Mol Cell Biol Res Commun; 2001 Nov; 4(6):365-73. PubMed ID: 11703096
[TBL] [Abstract][Full Text] [Related]
20. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.
Huhtala MT; Pentikäinen OT; Johnson MS
Structure; 1999 Jun; 7(6):699-709. PubMed ID: 10404599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]